14 May 2012, BioSpectrum Bureau , BioSpectrum
Singapore: The Joint Metabolomics Laboratory set up as a collaboration between Metabolon and Shanghai Jiao Tong University, China, has passed various stringent quality control processes and started operation.
Metabolon, a diagnostics and services company offering the industry's leading biochemical profiling technology, has implemented its technology platform at the laboratory. The collaboration will allow Metabolon to work with academic and industrial scientists within China or other Asian countries to perform biochemical profiling experiments with Metabolon's technology.
"The successful launch of the joint lab is a vital step in bringing the science of metabolomics to a significant, untapped market," said Mr John Ryals, CEO, Metabolon. "Our partnership with Shanghai Jiao Tong University is proof of Metabolon's efforts to bring personalized medicine and metabolic biomarker research to all parts of the world. We were able to completely replicate our complex mass spectrometry based methods in a remote location due to our highly engineered and quality controlled process."
The collaboration with SJTU will open up expansion possibilities for Metabolon to service previously difficult to access markets across the globe.